Revolution Medicines

RVMD · NASDAQ

$196.55+$14.40 (+7.91%)TodayMarket closed ·
Prev close $182.15

Who owns RVMD

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 47.1% of RVMD’s shares.

  • Farallon Capital Management, L.L.C.6.4%
  • Fidelity Management & Research Company LLC5.6%
  • Baker Bros. Advisors LP5.4%
  • Janus Henderson Investors5.0%
  • Next 6 largest institutions24.7%
  • All other shareholders52.9%
Top institutional holders of RVMD
HolderShares% of shares
Farallon Capital Management, L.L.C.13.55M6.37%
Fidelity Management & Research Company LLC11.97M5.63%
Baker Bros. Advisors LP11.44M5.38%
Janus Henderson Investors10.74M5.05%
Darwin Global Management Ltd10.63M5.00%
BlackRock Institutional Trust Company, N.A.10.47M4.92%
Vanguard Capital Management, LLC9.09M4.28%
Vanguard Portfolio Management, LLC8.29M3.90%
Nextech Invest, Ltd.7.60M3.58%
Paradigm BioCapital Advisors LP6.36M2.99%

Largest mutual fund holders

Top mutual fund holders of RVMD
HolderShares% of shares
Vanguard Total Stock Market Index Fund6.43M3.03%
Vanguard Small-Cap Index Fund4.64M2.18%
BB Biotech Fd4.58M2.15%
American Funds Growth Fund of America2.96M1.39%
Vanguard Small-Cap Growth Index Fund2.69M1.26%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $102.91M (112 trades) of RVMD on the open market, with no buys.

Latest RVMD insider transactions
InsiderTypeSharesValue
Sandler Alan B.Option exercise6.00K—
Sandler Alan B.Sale301$61.62K
Sandler Alan B.Sale1.20K$244.48K
Sandler Alan B.Sale1.00K$202.81K
Sandler Alan B.Sale1.61K$324.57K
Sandler Alan B.Sale2.20K$441.80K
Sandler Alan B.Option exercise6.00K$353.04K
Cislini JeffSale765$158.60K
Mancini AnthonyOption exercise3.12K—
Mancini AnthonySale3.12K$625.89K

Short interest

Settled Sep 30, 2026

Shares short
11.93M
Days to cover
4.65
% of shares outstanding
5.61%
Average daily volume
2.56M
Change since last report
+23.3%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.